TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Bionord Biokemi AB
Closing information (x1000 NOK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
65,612
|
66,260
|
65,966 |
| Financial expenses |
0
|
2
|
9 |
| Earnings before taxes |
7,774
|
7,134
|
6,777 |
| EBITDA |
7,697
|
7,140
|
6,835 |
| Total assets |
29,093
|
25,235
|
27,291 |
| Current assets |
26,515
|
22,702
|
24,869 |
| Current liabilities |
9,470
|
7,321
|
11,390 |
| Equity capital |
16,569
|
15,165
|
13,528 |
| - share capital |
516
|
507
|
473 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
57.0%
|
60.1%
|
49.6% |
| Turnover per employee |
13,122
|
11,043
|
13,193 |
| Profit as a percentage of turnover |
11.8%
|
10.8%
|
10.3% |
| Return on assets (ROA) |
26.7%
|
28.3%
|
24.9% |
| Current ratio |
280.0%
|
310.1%
|
218.3% |
| Return on equity (ROE) |
46.9%
|
47.0%
|
50.1% |
| Change turnover |
-1,843
|
-4,386
|
15,722 |
| Change turnover % |
-3%
|
-6%
|
31% |
| Chg. No. of employees |
-1
|
1
|
0 |
| Chg. No. of employees % |
-17%
|
20%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.